期刊文献+

奥氮平治疗精神分裂症的疗效与其血药浓度的相关性分析 被引量:7

下载PDF
导出
摘要 目的 探讨奥氮平治疗精神分裂症的疗效、副反应与血药浓度的关系 ,有效血药浓度的范围。方法 用阴性与阳性症状量表 (PANSS)、简明精神病评定量表 (BPRS)、社会功能缺陷筛选量表 (SDSS)和副反应量表 (TESS)评定疗效和副反应 ;用反相高效液相色谱法测定病人第 1、8周末的奥氮平血药浓度。结果 奥氮平能明显降低精神分裂症病人的阳性和阴性症状评分 (P <0 0 1) ,副反应主要为嗜睡、口干和体重增加。奥氮平的血药浓度个体差异较大 ,最高浓度为 5 9 83ng/mL ,最低浓度为 3 71ng/mL ,在此浓度范围内 ,奥氮平血药浓度与剂量成正相关 (r=0 3 3 ,P =0 0 2 1)。血药浓度大于 9ng/mL的病人疗效较好 (P <0 0 1) ;BPRS和SDSS的减分率与奥氮平血药浓度之间呈正相关 (P <0 0 5 )。结论 奥氮平能有效治疗精神分裂症 ,改善其社会功能障碍 ;其治疗精神分裂症的疗效与血药浓度有相关性 ,9ng/mL是奥氮平治疗精神分裂症适宜血药浓度的下限。
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2003年第5期363-365,共3页 Chinese Journal of Nervous and Mental Diseases
  • 相关文献

参考文献10

  • 1Frank P. In vivo and in vitro biochemistry of olanzapine. J Clin Psychiatry, 1997, 58(suppl 10): 28. 被引量:1
  • 2William M. The medical pattern of olanzapine and the new antipsychotic.J Clin Psychiatry, 1997, 58(suppl 10) : 18. 被引量:1
  • 3Charles M. The efficacy of olanzapine: the summary of global, multicentral clinical trials. J Clin Psychiatry, 1997, 58(suppl 10) : 7. 被引量:1
  • 4Kapus S, Zipursky RB, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine,risperidone,and olanzapine in schizophrenia.Am J Psychiatry, 1999, 156(2) : 286. 被引量:1
  • 5Olesen OV, Linnet K. Determination of olanzapine in senflla by high performance liquid chromatography using ultraviolet detection considefing the easy oxidability of the compound and the presence of other psychotic drugs.J Chromatography B, 1998, 714(4) : 309. 被引量:1
  • 6Ereshefsky L. Pharmacokinetics and drug inteeration:update for new antipsychotics.J Clin Psychiatry, 1996, 57(suppl 11): 12. 被引量:1
  • 7Robertson MD, Mcmullin MM. Olanzapine concentrations in clinical serum and postmortem blood specimens-when does therapeutic become toxic?J Forensic Sci, 2001; 45(2): 418. 被引量:1
  • 8Perry PJ, Todd S, Charles B. Olanzapine plasma concentrstions and clinical response in acutely ill schizophrenic patients.J Clin Psychophamacology,1997, 17(6):472. 被引量:1
  • 9Perry PJ, Lund BC, Sanger T, et al. Olanzapine plasma concentrations and clinical response:acute phase results of the North American Olanzapine Trial .J Clin Psychopharmacol, 2001, 21(1): 14.. 被引量:1
  • 10Aravagiri M, Ames D, Wirshing WC, et al. plasma level monitoring of loanzapine in patients with schizophrenia:determination by high performance liquid chromatography with electrochemical detection.Therapeutic Drug Monioring, 1997, 19(4): 307. 被引量:1

同被引文献236

  • 1杨献红,黄继忠,严和骎,江开达,陆峥,盛尤荣,熊祥玉,冯明德,姚维菊,吴敏.奥氮平治疗精神分裂症70例临床分析[J].上海精神医学,2002,14(2):94-96. 被引量:26
  • 2周旭辉,苏中华,邓慧琼,郝伟.湖南省怀化地区城乡饮酒吸烟状况及其影响因素研究[J].中国行为医学科学,2006,15(4):352-354. 被引量:20
  • 3于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330
  • 4Peuskens J, Bech P, Moller HJ, et al. Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Psychiatry Res ,1999, 88(2):107. 被引量:1
  • 5Rein W, Fleurot O, Danion JM. Amisulpride improves affective symptoms in acute schizophrenia. In: Abstracts of the XIth Congress of the European College of Neuropsychopharmacology, Paris31 October-4 November. European Neuropsychopharmacology,1998, 8: S.2, S231. 被引量:1
  • 6Paillere - Martinot ML, Lecrubier Y, Martinot JL, et al. Improvement of some schizophrenic deficit symptoms with low doses of amisulpride. Am J Psychiatry, 1995, 152:130. 被引量:1
  • 7McManus DQ, Arvanitis LA, Rowalcyk BB and the Seroquel Trial48 Study Group. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. J Clin Psychiatry, 1999,60:292. 被引量:1
  • 8Shaw JA, Lewis JE, Pascal S, et al. A study of quetiapine: efficacy and tolerability in psychotic adolescents. J Child Adolesc Psychopharrnacol, 2001, 11: 415. 被引量:1
  • 9Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study. Clin Ther, 2001, 23:1839. 被引量:1
  • 10Brecher M, Rak I, Melvin K, et al. The long - term effect of quetiapine monotherapy on weight in patients with schizophrenia. Int J Psychiatry Clin Pract, 2000, 4: 287. 被引量:1

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部